Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health study

<h3>Objectives</h3><p dir="ltr">To estimate lifetime prevalence, risk, and treatment for mental disorders and their correlates in Qatar's general population for the first time.</p><h3>Methods</h3><p dir="ltr">We conducted a national...

Full description

Saved in:
Bibliographic Details
Main Author: Salma Mawfek Khaled (14159013) (author)
Other Authors: Nour W. Z. Alhussaini (21841394) (author), Majid Alabdulla (12051430) (author), Nancy A. Sampson (7616513) (author), Ronald C. Kessler (7348619) (author), Peter W. Woodruff (14778967) (author), Sheik Mohammed Al‐Thani (21632897) (author)
Published: 2024
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513543069499392
author Salma Mawfek Khaled (14159013)
author2 Nour W. Z. Alhussaini (21841394)
Majid Alabdulla (12051430)
Nancy A. Sampson (7616513)
Ronald C. Kessler (7348619)
Peter W. Woodruff (14778967)
Sheik Mohammed Al‐Thani (21632897)
author2_role author
author
author
author
author
author
author_facet Salma Mawfek Khaled (14159013)
Nour W. Z. Alhussaini (21841394)
Majid Alabdulla (12051430)
Nancy A. Sampson (7616513)
Ronald C. Kessler (7348619)
Peter W. Woodruff (14778967)
Sheik Mohammed Al‐Thani (21632897)
author_role author
dc.creator.none.fl_str_mv Salma Mawfek Khaled (14159013)
Nour W. Z. Alhussaini (21841394)
Majid Alabdulla (12051430)
Nancy A. Sampson (7616513)
Ronald C. Kessler (7348619)
Peter W. Woodruff (14778967)
Sheik Mohammed Al‐Thani (21632897)
dc.date.none.fl_str_mv 2024-05-10T09:00:00Z
dc.identifier.none.fl_str_mv 10.1002/mpr.2011
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Lifetime_prevalence_risk_and_treatment_of_mood_and_anxiety_disorders_in_Qatar_s_national_mental_health_study/29714924
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Health sciences
Epidemiology
Health services and systems
Public health
5th edition (DSM‐5)
diagnostic and statistical manual
lifetime prevalence
lifetime treatment
mental disorder
Qatar
dc.title.none.fl_str_mv Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health study
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <h3>Objectives</h3><p dir="ltr">To estimate lifetime prevalence, risk, and treatment for mental disorders and their correlates in Qatar's general population for the first time.</p><h3>Methods</h3><p dir="ltr">We conducted a national phone survey of 5,195 Qatari and Arab residents in Qatar (2019–2022) using the Composite International Diagnostic Interview Version 3.3 and estimated lifetime mood and anxiety defined diagnoses. Survival‐based discrete time models, lifetime morbid risk, and treatment projections were estimated.</p><h3>Results</h3><p dir="ltr">Lifetime prevalence of any disorder was 28.0% and was associated with younger cohorts, females, and migrants, but lower formal education. Treatment contact in the year of disorder onset were 13.5%. The median delay in receiving treatment was 5 years (IQR = 2–13). Lifetime treatment among those with a lifetime disorder were 59.9% for non‐healthcare and 63.5% for healthcare; it was 68.1% for any anxiety and 80.1% for any mood disorder after 50 years of onset. Younger cohorts and later age of onset were significantly predictors of treatment.</p><h3>Conclusions</h3><p dir="ltr">Lifetime prevalence of mental disorders in Qatar is comparable to other countries. Treatment is significantly delayed and delivered largely in non‐healthcare sectors thus the need for increased literacy of mental illness to reduce stigma and improve earlier help‐seeking in healthcare settings.</p><h2>Other Information</h2><p dir="ltr">Published in: International Journal of Methods in Psychiatric Research<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1002/mpr.2011" target="_blank">https://dx.doi.org/10.1002/mpr.2011</a></p>
eu_rights_str_mv openAccess
id Manara2_4dddd656a2dfff6b0077a4f459408f68
identifier_str_mv 10.1002/mpr.2011
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/29714924
publishDate 2024
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health studySalma Mawfek Khaled (14159013)Nour W. Z. Alhussaini (21841394)Majid Alabdulla (12051430)Nancy A. Sampson (7616513)Ronald C. Kessler (7348619)Peter W. Woodruff (14778967)Sheik Mohammed Al‐Thani (21632897)Health sciencesEpidemiologyHealth services and systemsPublic health5th edition (DSM‐5)diagnostic and statistical manuallifetime prevalencelifetime treatmentmental disorderQatar<h3>Objectives</h3><p dir="ltr">To estimate lifetime prevalence, risk, and treatment for mental disorders and their correlates in Qatar's general population for the first time.</p><h3>Methods</h3><p dir="ltr">We conducted a national phone survey of 5,195 Qatari and Arab residents in Qatar (2019–2022) using the Composite International Diagnostic Interview Version 3.3 and estimated lifetime mood and anxiety defined diagnoses. Survival‐based discrete time models, lifetime morbid risk, and treatment projections were estimated.</p><h3>Results</h3><p dir="ltr">Lifetime prevalence of any disorder was 28.0% and was associated with younger cohorts, females, and migrants, but lower formal education. Treatment contact in the year of disorder onset were 13.5%. The median delay in receiving treatment was 5 years (IQR = 2–13). Lifetime treatment among those with a lifetime disorder were 59.9% for non‐healthcare and 63.5% for healthcare; it was 68.1% for any anxiety and 80.1% for any mood disorder after 50 years of onset. Younger cohorts and later age of onset were significantly predictors of treatment.</p><h3>Conclusions</h3><p dir="ltr">Lifetime prevalence of mental disorders in Qatar is comparable to other countries. Treatment is significantly delayed and delivered largely in non‐healthcare sectors thus the need for increased literacy of mental illness to reduce stigma and improve earlier help‐seeking in healthcare settings.</p><h2>Other Information</h2><p dir="ltr">Published in: International Journal of Methods in Psychiatric Research<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1002/mpr.2011" target="_blank">https://dx.doi.org/10.1002/mpr.2011</a></p>2024-05-10T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1002/mpr.2011https://figshare.com/articles/journal_contribution/Lifetime_prevalence_risk_and_treatment_of_mood_and_anxiety_disorders_in_Qatar_s_national_mental_health_study/29714924CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/297149242024-05-10T09:00:00Z
spellingShingle Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health study
Salma Mawfek Khaled (14159013)
Health sciences
Epidemiology
Health services and systems
Public health
5th edition (DSM‐5)
diagnostic and statistical manual
lifetime prevalence
lifetime treatment
mental disorder
Qatar
status_str publishedVersion
title Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health study
title_full Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health study
title_fullStr Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health study
title_full_unstemmed Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health study
title_short Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health study
title_sort Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health study
topic Health sciences
Epidemiology
Health services and systems
Public health
5th edition (DSM‐5)
diagnostic and statistical manual
lifetime prevalence
lifetime treatment
mental disorder
Qatar